By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews has extended the term of certain purchase warrants to July 31, 2012.

The warrants were issued by the Canadian molecular diagnostics firm on Jan. 16, 2009 and Feb. 11, 2009, entitling holders to purchase one common share of GeneNews at an exercise price of C$.25 ($US.25) per share.

There are 1 million warrants that were set to expire on Jan. 16, 2012, and there are 1,978,065 warrants that were set to expire on Feb. 11, 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.